{"disease":{"id":"cdkn2a-p16-positive","name":"cdkn2a p16 positive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03601507","title":"Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"University of Arizona","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}